EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyclin-Dependent Kinase Inhibitor 1A Betrays Early Liver Damage Driving Cancer: A Pilot Study

Ari Sánchez-Padilla, Amairani Escorcia-Barrera, Marco Antonio Tafoya-Olvera, Alejandra Idan Valencia-Cruz, José Luis García-Meza, Brisa Rodope Alarcón-Sánchez, Osiris Germán Idelfonso-García, Linda Vanessa Márquez-Quiroga, Julia Esperanza Torres-Mena, Sergio Fuentes-Hernández, Lorena Lizbeth Valderrama-Cervantes, Ema Elvira Herrera-López und 19 weitere

International Journal of Molecular Sciences · 11.11.2026 · 27 (22) · 10114

DOI: 10.3390/ijms272210114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.11.2026. Verfasst von Ari Sánchez-Padilla und 30 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Genomic Medicine, National Council for Humanities, Sciences and Technologies, SECIHTI.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) progresses asymptomatically over several decades after chronic exposure to multiple hepatotoxins. Here, we aimed to identify molecules revealing the malignant onset and progression of liver diseases. From a transcriptomic analysis of a HCC mouse model, ingenuity pathway analysis (IPA) was used to determine the involved causal signaling networks, and relevant genes were validated to identify early biomarkers. The relevant findings were validated in the blood of high-fat diet, alcohol-associated liver disease (ALD), and metabolic dysfunction-associated steatotic liver disease (MASLD) in vivo models, as well as in ALD patients. Ten IPA-predicted causal signaling networks were associated with HCC progression. The expression of cyclin-dependent kinase inhibitor 1a (Cdkn1a) gene, commonly known as P21, was the most dysregulated, and its total (CDN1A/P21) and phosphorylated protein level was increased from early to late stages. P21 was also increased and released into the bloodstream of ALD and MASLD models, both based on multiple hepatotoxins linked to HCC development, as well as in the bloodstream of ALD patients. In conclusion, P21 is altered from early stages of liver diseases leading to HCC, which betrays the onset of liver cancer before developing malignant traits; thus, P21 offers a critical therapeutic window for timely detection of high-risk patients.

Förderung

  • National Institute of Genomic Medicine
  • National Council for Humanities, Sciences and Technologies
  • SECIHTI

Zitieren

APA

Sánchez-Padilla, A., Escorcia-Barrera, A., Tafoya-Olvera, M. A., Valencia-Cruz, A. I., García-Meza, J. L., Alarcón-Sánchez, B. R., Idelfonso-García, O. G., Márquez-Quiroga, L. V., Torres-Mena, J. E., Fuentes-Hernández, S., Valderrama-Cervantes, L. L., Herrera-López, E. E., Aguirre-Maldonado, I., Martínez-Magaña, J. J., Resendis-Antonio, O., Muciño-Olmos, E. A., Aparicio-Bautista, D. I., Basurto-Islas, G., Román-González, S. A., …, & Arellanes-Robledo, J. (2026). Cyclin-Dependent Kinase Inhibitor 1A Betrays Early Liver Damage Driving Cancer: A Pilot Study. International Journal of Molecular Sciences, 27(22), 10114. https://doi.org/10.3390/ijms272210114

Vancouver

Sánchez-Padilla A, Escorcia-Barrera A, Tafoya-Olvera MA, Valencia-Cruz AI, García-Meza JL, Alarcón-Sánchez BR, et al. Cyclin-Dependent Kinase Inhibitor 1A Betrays Early Liver Damage Driving Cancer: A Pilot Study. International Journal of Molecular Sciences. 2026;27(22):10114. doi:10.3390/ijms272210114

BibTeX
@article{SnchezPadilla2026,
  author = {Sánchez-Padilla, Ari and Escorcia-Barrera, Amairani and Tafoya-Olvera, Marco Antonio and Valencia-Cruz, Alejandra Idan and García-Meza, José Luis and Alarcón-Sánchez, Brisa Rodope and Idelfonso-García, Osiris Germán and Márquez-Quiroga, Linda Vanessa and Torres-Mena, Julia Esperanza and Fuentes-Hernández, Sergio and Valderrama-Cervantes, Lorena Lizbeth and Herrera-López, Ema Elvira and Aguirre-Maldonado, Isaac and Martínez-Magaña, José Jaime and Resendis-Antonio, Osbaldo and Muciño-Olmos, Erick Andrés and Aparicio-Bautista, Diana Ivette and Basurto-Islas, Gustavo and Román-González, Sergio Agustín and Gutiérrez-Nava, María Angélica and Mendoza-Vargas, Alfredo and Jiménez-García, Mónica Noemí and Pacheco-Rivera, Ruth and Gutiérrez-Reyes, Gabriela and Pérez-Hernández, José Luis and Villa-Treviño, Saúl and Baltiérrez-Hoyos, Rafael and Vásquez-Garzón, Verónica Rocío and Muriel, Pablo and Pérez-Carreón, Julio Isael and Arellanes-Robledo, Jaime},
  title = {Cyclin-Dependent Kinase Inhibitor 1A Betrays Early Liver Damage Driving Cancer: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10114},
  doi = {10.3390/ijms272210114}
}
Kostenlos starten →